4.5 Article

Development and validation of an LC-ESI/MS/MS method with precolumn derivatization for the determination of betulin in rat plasma

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jchromb.2013.09.005

Keywords

Betulin; Precolumn derivatization; LC-ESI/MS/MS; p-Toluenesulfonyl isocyanate; Pharmacokinetics

Funding

  1. Forestry Industry Research Special Fund for Public Welfare [201004069]
  2. Fundamental Research Funds for the Central Universities [DL13EA02]
  3. Heilongjiang Provincial Natural Science Foundation of China [C201139]
  4. China Postdoctoral Science Foundation [2011M500630]
  5. Zhejiang Provincial Natural Science Foundation of China [Z2100435]

Ask authors/readers for more resources

Neutral pentacyclic triterpenes with only one or two hydroxyl groups, such as betulin, are not easily ionized by electrospray ionization (ESI). However, because betulin is reactive and neutral, derivatization may improve ionization efficiency. In the present study, the potency of different derivatization reagents was evaluated and p-toluenesulfonyl isocyanate (PTSI) was proven to be the optimal. The derivative generated by the reaction of betulin with PTSI was ionizable and fragmentable in the negative mode by liquid chromatography-electrospray ionization/tandem mass spectrometry (LC-ESI/MS/MS). Based on this chemical derivatization, an LC-ESI/MS/MS method was developed and validated for the quantification of betulin in rat plasma. The sample was extracted with ethyl acetate, derivatized with PTSI, separated on an ACQ UPLC BEH phenyl column, and analyzed in negative multiple reaction monitoring (MRM) mode. The calibration curve was linear over the betulin concentration range 2.5-200 ng/mL. The lower limit of quantification was 2.5 ng/mL. The inter- and intra-day accuracy and precision were within +/- 15%. Betulin recoveries were 86.7% or higher at three quality control levels (5, 50, and 160 ng/mL). This validated method was subsequently applied to a pharmacokinetic study of betulin in rat plasma after oral administration. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available